Capital World Investors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-841,900
Closed -$127M 573
2022
Q3
$127M Sell
841,900
-1,800,734
-68% -$272M 0.03% 312
2022
Q2
$385M Sell
2,642,634
-3,999,905
-60% -$583M 0.08% 211
2022
Q1
$788M Buy
6,642,539
+464,530
+8% +$55.1M 0.14% 167
2021
Q4
$851M Buy
6,178,009
+115,628
+2% +$15.9M 0.13% 160
2021
Q3
$842M Buy
6,062,381
+754
+0% +$105K 0.14% 159
2021
Q2
$588M Buy
6,061,627
+1,321,691
+28% +$128M 0.1% 197
2021
Q1
$324M Buy
4,739,936
+90,488
+2% +$6.18M 0.06% 242
2020
Q4
$399M Buy
4,649,448
+1,340,473
+41% +$115M 0.08% 222
2020
Q3
$215M Buy
3,308,975
+1,110,384
+51% +$72.2M 0.05% 259
2020
Q2
$161M Buy
2,198,591
+737
+0% +$53.9K 0.04% 268
2020
Q1
$74.8M Buy
2,197,854
+551,428
+33% +$18.8M 0.02% 296
2019
Q4
$89.6M Buy
1,646,426
+1,176,426
+250% +$64M 0.02% 315
2019
Q3
$19.6M Hold
470,000
﹤0.01% 410
2019
Q2
$20.6M Buy
+470,000
New +$20.6M ﹤0.01% 437